Cargando…

CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?

Amyotrophic lateral sclerosis (ALS) is a fatal progressive neurodegenerative disorder primarily characterized by selective degeneration of both the upper motor neurons in the brain and lower motor neurons in the brain stem and the spinal cord. The exact mechanism for the selective death of neurons i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tefera, Tesfaye Wolde, Steyn, Frederik J., Ngo, Shyuan T., Borges, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798275/ https://www.ncbi.nlm.nih.gov/pubmed/33431046 http://dx.doi.org/10.1186/s13578-020-00511-2

Ejemplares similares

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
por: Kirk, Siobhan E., et al.
Publicado: (2019)

Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
por: Tefera, Tesfaye W., et al.
Publicado: (2017)

Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions
por: Ngo, Shyuan T, et al.
Publicado: (2017)

Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Tefera, Tesfaye W., et al.
Publicado: (2016)

Skeletal muscle in amyotrophic lateral sclerosis
por: Shefner, Jeremy M, et al.
Publicado: (2023)

Altered skeletal muscle glucose–fatty acid flux in amyotrophic lateral sclerosis
por: Steyn, Frederik J, et al.
Publicado: (2020)

Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis
por: McGill, Raquel B, et al.
Publicado: (2020)

The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis
por: Ngo, S. T., et al.
Publicado: (2015)

Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis
por: Jiang, Leanne, et al.
Publicado: (2022)

Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?
por: Quessada, Cyril, et al.
Publicado: (2021)

Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1(G93A) mice
por: Scaricamazza, Silvia, et al.
Publicado: (2022)

Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet
por: Lerskiatiphanich, Titaya, et al.
Publicado: (2022)

CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
por: Evans, Matthew C, et al.
Publicado: (2014)

Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis
por: Chang, Jeryn, et al.
Publicado: (2022)

Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019)

The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
por: Amin, Azin, et al.
Publicado: (2020)

Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation
por: Forsberg, Karin M., et al.
Publicado: (2022)

The complexity of multidisciplinary respiratory care in amyotrophic lateral sclerosis
por: Berlowitz, David J., et al.
Publicado: (2023)

Therapeutic Approaches Targeting Protein Aggregation in Amyotrophic Lateral Sclerosis
por: Malik, Ravinder, et al.
Publicado: (2020)

Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis
por: Li, Wenxue, et al.
Publicado: (2022)

Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
por: Szelechowski, M., et al.
Publicado: (2018)

Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
por: Morrison, Brett, et al.
Publicado: (2012)

Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications
por: Steinruecke, Moritz, et al.
Publicado: (2023)

Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets
por: Jiang, Zongzhi, et al.
Publicado: (2022)

5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis
por: Jiang, Shi-Shi, et al.
Publicado: (2023)

Altered RNA metabolism and amyotrophic lateral sclerosis
por: Verma, Ashok
Publicado: (2011)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis
por: Mathis, Stéphane, et al.
Publicado: (2018)

Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
por: Webster, Christopher P., et al.
Publicado: (2017)

Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis
por: Guo, Wenting, et al.
Publicado: (2017)

Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
por: Proaño, Belén, et al.
Publicado: (2022)

Glia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets
por: Ban, Jelena, et al.
Publicado: (2019)

Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations
por: Park, Hee Ra, et al.
Publicado: (2021)

Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle
por: Tarantino, Nancy, et al.
Publicado: (2022)

Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy
por: Suzuki, Naoki, et al.
Publicado: (2022)

A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis
por: Palamiuc, Lavinia, et al.
Publicado: (2015)

Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1
por: Restuadi, Restuadi, et al.
Publicado: (2022)

Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis
por: Buhour, M-S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_66ik372h1irdu61ntob5mj2eq6